Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Insulin Glargine Mixed With Regular Insulin Versus the Standard Neutral Protamine Hagedorn (NPH) and Regular Insulin in the Treatment of Type 1 Diabetes Mellitus

NCT05709938 is registered in ClinicalTrials.gov with King Edward Medical University as lead sponsor.

NCT NCT05709938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05709938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Insulin Glargine Mixed With Regular Insulin Versus the Standard Neutral Protamine Hagedorn (NPH) and Regular Insulin in the Treatment of Type 1 Diabetes Mellitus
Lead sponsor
King Edward Medical University
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2019
Completion date
April 20, 2021
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to assess the glycemic control of insulin glargine in combination with regular insulin in type 1 diabetes in children